These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28936523)

  • 21. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
    Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
    Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant.
    Guo L; Chen J; Qiu Y; Zhang S; Xu B; Gao Y
    Int J Pharm; 2013 Apr; 447(1-2):22-30. PubMed ID: 23410987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simple nanoliposomes encapsulating
    Bo R; Sun Y; Zhou S; Ou N; Gu P; Liu Z; Hu Y; Liu J; Wang D
    Int J Nanomedicine; 2017; 12():6289-6301. PubMed ID: 28894367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
    Slütter B; Bal SM; Que I; Kaijzel E; Löwik C; Bouwstra J; Jiskoot W
    Mol Pharm; 2010 Dec; 7(6):2207-15. PubMed ID: 21043518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice.
    Maletto B; Rópolo A; Morón V; Pistoresi-Palencia MC
    J Leukoc Biol; 2002 Sep; 72(3):447-54. PubMed ID: 12223511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses.
    Kang S; Ahn S; Lee J; Kim JY; Choi M; Gujrati V; Kim H; Kim J; Shin EC; Jon S
    J Control Release; 2017 Jun; 256():56-67. PubMed ID: 28428066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An injectable, low-toxicity phospholipid-based phase separation gel that induces strong and persistent immune responses in mice.
    Han L; Xue J; Wang L; Peng K; Zhang Z; Gong T; Sun X
    Biomaterials; 2016 Oct; 105():185-194. PubMed ID: 27522253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
    Gieni RS; Yang X; Kelso A; Hayglass KT
    Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidized carbon nanoparticles as an effective protein antigen delivery system targeting the cell-mediated immune response.
    Sawutdeechaikul P; Jiangchareon B; Wanichwecharungruang S; Palaga T
    Int J Nanomedicine; 2019; 14():4867-4880. PubMed ID: 31308663
    [No Abstract]   [Full Text] [Related]  

  • 30. Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity.
    Rietscher R; Schröder M; Janke J; Czaplewska J; Gottschaldt M; Scherließ R; Hanefeld A; Schubert US; Schneider M; Knolle PA; Lehr CM
    Eur J Pharm Biopharm; 2016 May; 102():20-31. PubMed ID: 26940132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcutaneous delivery of a nanoencapsulated antigen: induction of immune responses.
    Mattheolabakis G; Lagoumintzis G; Panagi Z; Papadimitriou E; Partidos CD; Avgoustakis K
    Int J Pharm; 2010 Jan; 385(1-2):187-93. PubMed ID: 19874877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Highly versatile immunostimulating nanocapsules for specific immune potentiation.
    Vicente S; Peleteiro M; Gonzalez-Aramundiz JV; Díaz-Freitas B; Martínez-Pulgarín S; Neissa JI; Escribano JM; Sanchez A; González-Fernández A; Alonso MJ
    Nanomedicine (Lond); 2014 Oct; 9(15):2273-89. PubMed ID: 24673264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diesel exhaust, carbon black, and silica particles display distinct Th1/Th2 modulating activity.
    van Zijverden M; van der Pijl A; Bol M; van Pinxteren FA; de Haar C; Penninks AH; van Loveren H; Pieters R
    Toxicol Appl Pharmacol; 2000 Oct; 168(2):131-9. PubMed ID: 11032768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An aluminum adjuvant-integrated nano-MOF as antigen delivery system to induce strong humoral and cellular immune responses.
    Zhong X; Zhang Y; Tan L; Zheng T; Hou Y; Hong X; Du G; Chen X; Zhang Y; Sun X
    J Control Release; 2019 Apr; 300():81-92. PubMed ID: 30826373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibronectin-binding protein I of Streptococcus pyogenes is a promising adjuvant for antigens delivered by mucosal route.
    Medina E; Talay SR; Chhatwal GS; Guzmán CA
    Eur J Immunol; 1998 Mar; 28(3):1069-77. PubMed ID: 9541603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant effects of salidroside from Rhodiola rosea L. on the immune responses to ovalbumin in mice.
    Guan S; He J; Guo W; Wei J; Lu J; Deng X
    Immunopharmacol Immunotoxicol; 2011 Dec; 33(4):738-43. PubMed ID: 21711135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amorphous nanosilica particles block induction of oral tolerance in mice.
    Toda T; Yoshino S
    J Immunotoxicol; 2016 Sep; 13(5):723-8. PubMed ID: 27086695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of CD4+ and CD8+ T cells in adjuvant activity of diesel exhaust particles in mice.
    Fujimaki H; Ui N; Ushio H; Nohara K; Endo T
    Int Arch Allergy Immunol; 2001 Apr; 124(4):485-96. PubMed ID: 11340332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.
    Schmidt ST; Khadke S; Korsholm KS; Perrie Y; Rades T; Andersen P; Foged C; Christensen D
    J Control Release; 2016 Oct; 239():107-17. PubMed ID: 27574990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.